Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...

A new study published in the journal of Frontiers in Cardiovascular Medicine revealed that Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) were associated with improved left ...

Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk.

Most of us associate neuromodulators like Botox with an image of a syringe poised precisely above the forehead or between a ...

A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.

A new study from researchers at Johns Hopkins Medicine shows that a very small detail during a blood pressure test can change ...

There was a consensus that more data are needed to answer this question, with discussions about what such a trial would look ...

The clinical results were presented by Dr. Amish Raval, M.D., Professor of Medicine at University of Wisconsin School of Medicine and Public Health and CardiAMP HF Trial National Co-Principal ...

Today’s column is the second in a series about major risk factors for heart attacks. A majority of Americans eventually develop artery-damaging hypertension. High BP is called “the silent killer” ...

Adolescents deserve protection, not addiction,’ say researchers as study highlights risk of nicotine products on hypertension ...

India bears a disproportionate share of the global diabetes burden, with 89.8 million adults living with T2DM against a ...

PEOPLE who vape or smoke just once a week could be almost 50 per cent more likely to develop high blood pressure, a new study ...